Skip to main content

Table 2 Comparisons between the treated Group and the Normal Control Group

From: Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells

 

Treated (n = 42)

Control (n = 42)

p-valuea

IOP(mmHg)

11.48 ± 2.22

12.64 ± 3.81

0.09

CD(cells/mm2)

2605.01 ± 399.08

2583.90 ± 377.20

0.80

CV

64.65 ± 32.90

71.75 ± 37.47

0.36

6A(%)

39.95 ± 10.77

40.71 ± 13.52

0.78

CCT(μm)

508.01 ± 32.54

507.21 ± 31.56

0.91

  1. IOP intraocular pressure, CD corneal density, CV coefficient of variation, 6A hexagonality, CCT central corneal thickness
  2. aOne-way ANOVA test